{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:16:42Z","timestamp":1791465402179,"version":"4.3.4"},"reference-count":159,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010941","name":"University of Vermont","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001960","name":"American Society for Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.prro.2024.05.007","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T08:05:51Z","timestamp":1718697951000},"page":"398-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline"],"prefix":"10.1016","volume":"14","author":[{"given":"Danielle N.","family":"Margalit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalis","family":"Aristophanous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musaddiq","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal K.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bradfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Califano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy J.","family":"Caudell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina H.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Garden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Maghami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranee","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelizaveta","family":"Shnayder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Swiecicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian Chiaojung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2024.05.007_bib0001","series-title":"Clinical Practice Guidelines We Can Trust","year":"2011"},{"key":"10.1016\/j.prro.2024.05.007_bib0002","series-title":"Finding What Works in Health Care: Standards for Systematic Reviews","author":"Eden","year":"2011"},{"key":"10.1016\/j.prro.2024.05.007_bib0003","unstructured":"CDC. Cancers Associated with Human Papillomavirus, United States\u20142015-2019. Centers for Disease Control and Prevention website. 2022.https:\/\/www.cdc.gov\/united-states-cancer-statistics\/publications\/hpv-associated-cancers.html#cdc_research_or_data_summary_suggested_citation-suggested-citation Accessed September 29, 2023."},{"key":"10.1016\/j.prro.2024.05.007_bib0004","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.2017.75.0141","article-title":"Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States","volume":"36","author":"Chaturvedi","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0005","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1158\/1055-9965.EPI-19-0038","article-title":"Incidence and demographic burden of HPV-associated oropharyngeal head and neck cancers in the United States","volume":"28","author":"Mahal","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.prro.2024.05.007_bib0006","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1200\/JCO.22.02625","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"41","author":"Chaturvedi","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0007","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.prro.2017.02.002","article-title":"Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline","volume":"7","author":"Sher","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): A randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2024.05.007_bib0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): An open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2024.05.007_bib0010","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2014.55.3925","article-title":"Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: Long-term report of efficacy and toxicity","volume":"32","author":"Nguyen-Tan","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0011","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0012","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.prro.2024.05.007_bib0013","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0014","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prro.2024.05.007_bib0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2021.01.013","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group","volume":"156","author":"Lacas","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0017","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijrobp.2017.01.018","article-title":"Re-evaluation of ipsilateral radiation for T1-T2N0-N2b tonsil carcinoma at the Princess Margaret Hospital in the human papillomavirus era, 25 years later","volume":"98","author":"Huang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0018","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","article-title":"Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)","volume":"76","author":"Eisbruch","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0019","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ijrobp.2022.04.035","article-title":"Unilateral radiation therapy for tonsillar cancer: Treatment outcomes in the era of human papillomavirus, positron-emission tomography, and intensity modulated radiation therapy","volume":"113","author":"Taku","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0020","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12094-020-02467-8","article-title":"Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: Follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial","volume":"23","author":"Hitt","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0021","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial","volume":"14","author":"Haddad","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0022","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2013.54.6309","article-title":"Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer","volume":"32","author":"Cohen","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0023","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.20.02072","article-title":"ARTSCAN III: A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer","volume":"39","author":"Gebre-Medhin","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0024","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2021.04.015","article-title":"Randomized trial of radiation therapy with weekly cisplatin or cetuximab in low-risk HPV-associated oropharyngeal cancer (TROG 12.01)\u2014A Trans-Tasman Radiation Oncology Group Study","volume":"111","author":"Rischin","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0026","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2024.05.007_bib0027","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/030089160609200108","article-title":"Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx","volume":"92","author":"Fallai","year":"2006","journal-title":"Tumori"},{"key":"10.1016\/j.prro.2024.05.007_bib0028","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","article-title":"Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: A randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","volume":"22","author":"Lee","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.annonc.2022.10.006","article-title":"Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): A multicenter, randomized, phase II trial","volume":"34","author":"Tao","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijrobp.2020.02.637","article-title":"Cetuximab and radiation therapy versus cisplatin and radiation therapy for locally advanced head and neck cancer: Long-term survival and toxicity outcomes of a randomized phase 2 trial","volume":"107","author":"Maddalo","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0031","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<876::AID-CNCR19>3.0.CO;2-Y","article-title":"Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck","volume":"88","author":"Adelstein","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2024.05.007_bib0032","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2024.05.007_bib0033","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1200\/JCO.2013.53.5633","article-title":"Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522","volume":"32","author":"Ang","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0034","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0035","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1200\/JCO.22.00980","article-title":"Results of phase III randomized trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer, unsuitable for cisplatin-based chemoradiation","volume":"41","author":"Patil","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0036","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0360-3016(00)00408-9","article-title":"The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck","volume":"47","author":"Suntharalingam","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0037","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1200\/JCO.2009.24.6199","article-title":"Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: Clinical and functional results","volume":"28","author":"Feng","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0038","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0039","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ijrobp.2012.05.008","article-title":"Long-term follow-up of the RTOG 9501\/intergroup phase III trial: Postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck","volume":"84","author":"Cooper","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0040","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2024.05.007_bib0041","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2024.05.007_bib0042","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/hed.20279","article-title":"Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)","volume":"27","author":"Bernier","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2024.05.007_bib0043","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijrobp.2017.02.218","article-title":"Final report of a prospective randomized trial to evaluate the dose-response relationship for postoperative radiation therapy and pathologic risk groups in patients with head and neck cancer","volume":"98","author":"Rosenthal","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0044","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.oraloncology.2018.05.026","article-title":"Magnitude of benefit for adjuvant radiotherapy following minimally invasive surgery in intermediate to high risk HPV-positive oropharyngeal squamous cell carcinoma","volume":"82","author":"Pasalic","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0045","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.21873\/anticanres.13674","article-title":"Clinical outcomes of head and neck cancer patients who undergo resection, but forgo adjuvant therapy","volume":"39","author":"Loganadane","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.prro.2024.05.007_bib0046","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/onco.13742","article-title":"De-escalated adjuvant therapy after transoral robotic surgery for human papillomavirus-related oropharyngeal carcinoma: The Sinai Robotic Surgery (SIRS) Trial","volume":"26","author":"Miles","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.prro.2024.05.007_bib0047","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hed.26578","article-title":"Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapy","volume":"43","author":"Carey","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2024.05.007_bib0048","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1002\/cncr.33611","article-title":"Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients","volume":"127","author":"Ryan","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2024.05.007_bib0049","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/hed.23229","article-title":"Prognostic factors in limited (T1-2, N0-1) oropharyngeal carcinoma treated with surgery +\/- adjuvant therapy","volume":"35","author":"Psychogios","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2024.05.007_bib0050","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hed.20794","article-title":"Value of postoperative radiotherapy in patients with pathologic N1 neck disease","volume":"30","author":"Jackel","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2024.05.007_bib0051","doi-asserted-by":"crossref","first-page":"E2865","DOI":"10.1002\/lary.29659","article-title":"Locoregional recurrence in p16-positive oropharyngeal squamous cell carcinoma after TORS","volume":"131","author":"Carey","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.prro.2024.05.007_bib0052","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3390\/cancers15061833","article-title":"Adjuvant radiotherapy in patients with squamous cell carcinoma of the oral cavity or oropharynx and solitary ipsilateral lymph node metastasis (pN1)\u2014A prospective multicentric cohort study","volume":"15","author":"Kammerer","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prro.2024.05.007_bib0053","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.21.01293","article-title":"Weekly cisplatin plus radiation for postoperative head and neck cancer (JCOG1008): A multicenter, noninferiority, phase II\/III randomized controlled trial","volume":"40","author":"Kiyota","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0054","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1200\/JCO.2017.74.9457","article-title":"Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: A phase III randomized noninferiority trial","volume":"36","author":"Noronha","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0055","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/s12885-015-1598-x","article-title":"PATHOS: A phase II\/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV) positive oropharyngeal cancer","volume":"15","author":"Owadally","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prro.2024.05.007_bib0056","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/MLG.0b013e31815b48f4","article-title":"Long-term results of a phase III randomized trial of postoperative radiotherapy with or without carboplatin in patients with high-risk head and neck cancer","volume":"118","author":"Argiris","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.prro.2024.05.007_bib0057","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/hed.26928","article-title":"The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures","volume":"44","author":"Dhere","year":"2022","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2024.05.007_bib0058","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0266-4356(03)00119-0","article-title":"Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer","volume":"41","author":"McMahon","year":"2003","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.prro.2024.05.007_bib0059","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2020.05.021","article-title":"Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial","volume":"150","author":"Tao","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":"A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0061","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2011.02.010","article-title":"The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial","volume":"100","author":"Lassen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0062","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","article-title":"Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis","volume":"18","author":"Lacas","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0063","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ijrobp.2015.12.380","article-title":"Elective nodal irradiation and patterns of failure in head and neck cancer after primary radiation therapy","volume":"94","author":"Kjems","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0064","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2015.09.024","article-title":"Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma\u2014The ARTSCAN trial","volume":"117","author":"Zackrisson","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0065","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2024.05.007_bib0066","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1200\/JCO.2006.08.057","article-title":"Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: A GORTEC trial","volume":"24","author":"Bourhis","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0067","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/hed.24486","article-title":"Reevaluation of postoperative radiation dose in the management of human papillomavirus-positive oropharyngeal cancer","volume":"38","author":"Chin","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2024.05.007_bib0068","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.prro.2016.11.002","article-title":"Sparing of high retropharyngeal nodal basins in patients with unilateral oropharyngeal carcinoma treated with intensity modulated radiation therapy","volume":"7","author":"Leeman","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0069","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1002\/cncr.28938","article-title":"Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life","volume":"120","author":"Spencer","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2024.05.007_bib0070","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jamaoncol.2021.6416","article-title":"Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirus-associated oropharyngeal carcinoma treated with definitive chemoradiotherapy","volume":"8","author":"Tsai","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0071","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.radonc.2021.07.016","article-title":"Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes","volume":"162","author":"Al-Mamgani","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0072","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.clon.2021.07.009","article-title":"Improvement in dysphagia outcomes following clinical target volume reduction in the De-ESCALaTE study","volume":"33","author":"Vreugdenhil","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.prro.2024.05.007_bib0073","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4143\/crt.2016.425","article-title":"Comparison of the clinical outcomes of patients with squamous cell carcinoma of the tonsil receiving postoperative ipsilateral versus bilateral neck radiotherapy: A propensity score matching analysis (KROG 11-07)","volume":"49","author":"Kim","year":"2017","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.prro.2024.05.007_bib0074","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.radonc.2012.12.006","article-title":"Unilateral neck irradiation for well-lateralized oropharyngeal cancer","volume":"106","author":"Al-Mamgani","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0075","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0360-3016(01)01613-3","article-title":"The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region","volume":"51","author":"O'Sullivan","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105566","article-title":"Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience","volume":"122","author":"Rosenberg","year":"2021","journal-title":"Oral Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0077","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1200\/JCO.2016.68.3300","article-title":"E1308: Phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx\u2014ECOG-ACRIN Cancer Research Group","volume":"35","author":"Marur","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0078","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0079","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1470-2045(23)00265-6","article-title":"Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): A phase 3, multicentre, randomised, controlled trial","volume":"24","author":"Nutting","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-8140(92)90242-M","article-title":"Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy","volume":"25","author":"Horiot","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0081","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11136-020-02628-w","article-title":"Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma: results on the quality of life","volume":"30","author":"Deschuymer","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.prro.2024.05.007_bib0082","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2019.07.025","article-title":"18F-FDG-PET\/CT-based treatment planning for definitive (chemo)radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival","volume":"142","author":"van den Bosch","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0083","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2024.05.007_bib0084","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/ans.17463","article-title":"Avoidance of primary site adjuvant radiotherapy following transoral robotic surgery: A cohort study","volume":"92","author":"Fradet","year":"2022","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.prro.2024.05.007_bib0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ijrobp.2019.11.021","article-title":"A phase 2 trial of alternative volumes of oropharyngeal irradiation for de-intensification (AVOID): Omission of the resected primary tumor bed after transoral robotic surgery for human papilloma virus-related squamous cell carcinoma of the oropharynx","volume":"106","author":"Swisher-McClure","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0086","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ijrobp.2020.09.063","article-title":"Prospective phase 2 study of radiation therapy dose and volume de-escalation for elective neck treatment of oropharyngeal and laryngeal cancer","volume":"109","author":"Sher","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0087","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gregoire","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0088","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/COC.0000000000000064","article-title":"Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes","volume":"38","author":"Tam","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0089","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.oraloncology.2016.04.011","article-title":"Cervical nodal level V can safely be omitted in the treatment of locally advanced oropharyngeal squamous cell carcinoma with definitive IMRT","volume":"58","author":"Gutiontov","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2017.08.002","article-title":"Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life","volume":"126","author":"Hawkins","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106362","article-title":"Low contralateral neck recurrence risk with ipsilateral neck radiotherapy in N2b tonsillar squamous cell carcinoma","volume":"139","author":"Natesan","year":"2023","journal-title":"Oral Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0092","article-title":"Impact of oral cavity dosimetry on patient reported xerostomia and dysgeusia in the setting of deintensified chemoradiotherapy","volume":"7","author":"Fried","year":"2022","journal-title":"Adv. Radiat Oncol."},{"key":"10.1016\/j.prro.2024.05.007_bib0093","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.radonc.2015.11.009","article-title":"Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: Clinical validation according to the model-based approach","volume":"118","author":"Christianen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0094","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00066-022-01992-5","article-title":"Impact of dosimetric factors on long-term percutaneous enteral gastrostomy (PEG) tube dependence in head and neck cancer patients after (chemo)radiotherapy-results from a prospective randomized trial","volume":"198","author":"Loser","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.prro.2024.05.007_bib0095","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2016.09.001","article-title":"Dysphagia\u2014Results from multivariable predictive modelling on aspiration from a subset of the ARTSCAN trial","volume":"122","author":"Soderstrom","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0096","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.radonc.2021.01.024","article-title":"Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment","volume":"157","author":"Van den Bosch","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.17.00070","article-title":"Modeling dose response for late dysphagia in patients with head and neck cancer in the modern era of definitive chemoradiation","volume":"1","author":"Tsai","year":"2017","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.prro.2024.05.007_bib0098","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.radonc.2008.03.010","article-title":"Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone","volume":"87","author":"Poulsen","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0099","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1080\/0284186X.2019.1643037","article-title":"Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: Risk factors and dose-volume correlations","volume":"58","author":"Aarup-Kristensen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0100","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1002\/cncr.30803","article-title":"Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy","volume":"123","author":"Caparrotti","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2024.05.007_bib0101","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2012.05.032","article-title":"Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer","volume":"85","author":"Tsai","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"10.1016\/j.prro.2024.05.007_bib0102","first-page":"E1481","article-title":"Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results","volume":"38","author":"Ghosh-Laskar","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2024.05.007_bib0103","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.radonc.2012.07.001","article-title":"Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial","volume":"104","author":"Gupta","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0104","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13014-020-01666-5","article-title":"Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial","volume":"15","author":"Gupta","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0106","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00066-020-01737-2","article-title":"Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy","volume":"197","author":"Tribius","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.prro.2024.05.007_bib0107","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.radonc.2013.03.006","article-title":"The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT","volume":"106","author":"Miah","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0108","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2009.07.1708","article-title":"Parotid gland function after radiotherapy: The combined michigan and utrecht experience","volume":"78","author":"Dijkema","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0109","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ijrobp.2009.08.078","article-title":"Radiation associated brainstem injury","volume":"76","author":"Mayo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0110","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.ijrobp.2011.10.052","article-title":"Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms","volume":"83","author":"Pak","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0111","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2014.02.019","article-title":"Beam path toxicity in candidate organs-at-risk: Assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy","volume":"111","author":"Kocak-Uzel","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0112","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/j.prro.2021.12.006","article-title":"Clinical Use of A priori knowledge of organ-at-risk sparing during radiation therapy treatment for oropharyngeal cancer: Dosimetric and patient reported outcome improvements","volume":"12","author":"Fried","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0113","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/0284186X.2021.2022198","article-title":"Swallowing sparing intensity modulated radiotherapy versus standard parotid sparing intensity-modulated radiotherapy for treatment of head and neck cancer: A randomized clinical trial","volume":"61","author":"Ashour","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0114","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.ijrobp.2010.12.067","article-title":"Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: Swallowing organs late complication probabilities and dosimetric correlates","volume":"81","author":"Eisbruch","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/cncr.33948","article-title":"Exposed bone in patients with head and neck cancer treated with radiation therapy: An analysis of the Observational Study of Dental Outcomes in Head and Neck Cancer Patients (OraRad)","volume":"128","author":"Treister","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2024.05.007_bib0116","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41415-021-3536-4","article-title":"Dental loss after radiotherapy for head and neck cancer","volume":"231","author":"Kovarik","year":"2021","journal-title":"Br Dent J"},{"key":"10.1016\/j.prro.2024.05.007_bib0117","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/cid.13005","article-title":"Significance of site-specific radiation dose and technique for success of implant-based prosthetic rehabilitation in irradiated head and neck cancer patients\u2014A cohort study","volume":"23","author":"Wolf","year":"2021","journal-title":"Clin Implant Dent Relat Res"},{"key":"10.1016\/j.prro.2024.05.007_bib0118","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.ijrobp.2009.04.096","article-title":"Radiation therapy and hearing loss","volume":"76","author":"Bhandare","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0119","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13014-015-0501-x","article-title":"Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy","volume":"10","author":"Lee","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0120","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hed.24643","article-title":"Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation","volume":"39","author":"Ling","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2024.05.007_bib0121","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.adro.2019.08.006","article-title":"Radiation-induced hypothyroidism after radical intensity modulated radiation therapy for oropharyngeal carcinoma","volume":"5","author":"Kamal","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0122","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2013.06.029","article-title":"Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: Normal tissue complication probability modeling with latent time correction","volume":"109","author":"Ronjom","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0123","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/hed.23482","article-title":"Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: Prospective data from 2 randomized controlled trials","volume":"36","author":"Murthy","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2024.05.007_bib0124","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1259\/bjr\/62332495","article-title":"Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer","volume":"84","author":"Chen","year":"2011","journal-title":"Br J Radiol"},{"key":"10.1016\/j.prro.2024.05.007_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.oraloncology.2018.02.021","article-title":"The risk of carotid stenosis in head and neck cancer patients after radiation therapy","volume":"80","author":"Carpenter","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0126","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1200\/JCO.2008.16.6546","article-title":"Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy","volume":"26","author":"Smith","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0127","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-CT surveillance versus neck dissection in advanced head and neck cancer","volume":"374","author":"Mehanna","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2024.05.007_bib0128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejrad.2018.12.004","article-title":"Prospective comparative study of MRI including diffusion-weighted images versus FDG PET-CT for the detection of recurrent head and neck squamous cell carcinomas after (chemo)radiotherapy","volume":"111","author":"Driessen","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.prro.2024.05.007_bib0129","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00330-015-3902-1","article-title":"FDG-PET\/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET\/non-contrast-enhanced CT and contrast-enhanced CT","volume":"26","author":"Suenaga","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.prro.2024.05.007_bib0130","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1200\/JCO.2017.73.5845","article-title":"Fluorodeoxyglucose-positron emission tomography\/computed tomography after concurrent chemoradiotherapy in locally advanced head-and-neck squamous cell cancer: The ECLYPS study","volume":"35","author":"Van den Wyngaert","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0131","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00405-019-05684-2","article-title":"FDG-PET\/CT in the surveillance of head and neck cancer following radiotherapy","volume":"277","author":"Risor","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.prro.2024.05.007_bib0132","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hed.25425","article-title":"Posttreatment surveillance PET\/CT for HPV-associated oropharyngeal cancer","volume":"41","author":"Corpman","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2024.05.007_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105870","article-title":"Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection","volume":"128","author":"Zhou","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0134","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00405-019-05340-9","article-title":"FDG-PET\/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation","volume":"276","author":"de Ridder","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.prro.2024.05.007_bib0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2020.03.032","article-title":"FDG-PET\/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status","volume":"148","author":"Urban","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0136","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.radonc.2020.08.004","article-title":"The declining role of post-treatment neck dissection in human papillomavirus-associated oropharyngeal cancer","volume":"151","author":"Daniels","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0137","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3390\/cancers13061461","article-title":"Role of repeat PET\/CT imaging in head and neck cancer following initial incomplete PET\/CT response to chemoradiation","volume":"13","author":"Iovoli","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prro.2024.05.007_bib0138","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.oraloncology.2018.11.033","article-title":"Utility of a repeat PET\/CT scan in HPV-associated oropharyngeal cancer following incomplete nodal response from (chemo)radiotherapy","volume":"88","author":"Liu","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0139","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/ijc.28120","article-title":"Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer","volume":"133","author":"Goenka","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.prro.2024.05.007_bib0140","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1002\/cncr.28831","article-title":"Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer","volume":"120","author":"Garden","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2024.05.007_bib0141","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1200\/JCO.2005.04.6052","article-title":"Postradiotherapy neck dissection for lymph node-positive head and neck cancer: The use of computed tomography to manage the neck","volume":"24","author":"Liauw","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0142","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.oraloncology.2014.12.009","article-title":"Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy","volume":"51","author":"Sjovall","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.prro.2024.05.007_bib0143","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4103\/jcrt.JCRT_542_17","article-title":"Prognostic value of response assessment fluorodeoxyglucose positron emission tomography-computed tomography scan in radically treated squamous cell carcinoma of head and neck: Long-term results of a prospective study","volume":"15","author":"Ghosh-Laskar","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.prro.2024.05.007_bib0144","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1017\/S0022215122000317","article-title":"Systematic review and meta-analysis of the diagnostic effectiveness of positron emission tomography-computed tomography versus magnetic resonance imaging in the post-treatment surveillance of head and neck squamous cell carcinoma","volume":"137","author":"Zhu","year":"2023","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.prro.2024.05.007_bib0145","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3174\/ajnr.A5767","article-title":"Negative predictive value of NI-RADS category 2 in the first posttreatment FDG-PET\/CT in head and neck squamous cell carcinoma","volume":"39","author":"Wangaryattawanich","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.prro.2024.05.007_bib0146","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1038\/s41598-020-60739-3","article-title":"Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort","volume":"10","author":"Zhong","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.prro.2024.05.007_bib0147","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/hed.27160","article-title":"Posttreatment FDG-PET\/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma","volume":"44","author":"Miller","year":"2022","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2024.05.007_bib0148","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2967\/jnumed.113.136796","article-title":"Head and neck PET\/CT: therapy response interpretation criteria (Hopkins Criteria)\u2014interreader reliability, accuracy, and survival outcomes","volume":"55","author":"Marcus","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2024.05.007_bib0149","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3857\/roj.2011.29.4.243","article-title":"FDG-PET\/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer","volume":"29","author":"Kim","year":"2011","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.prro.2024.05.007_bib0150","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/coa.12998","article-title":"A real-time prediction model for post-irradiation malignant cervical lymph nodes","volume":"43","author":"Lo","year":"2018","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.prro.2024.05.007_bib0151","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2013.08.049","article-title":"Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status","volume":"87","author":"Huang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0152","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3390\/v14081693","article-title":"Post-treatment neck dissection of tonsillar and base of tongue squamous cell carcinoma in the era of PET-CT, HPV, and p16","volume":"14","author":"Landin","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.prro.2024.05.007_bib0153","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/cancers15020464","article-title":"Clinical utility of second-look FDG PET-CT to stratify incomplete metabolic response post (chemo) radiotherapy in oropharyngeal squamous cell carcinoma","volume":"15","author":"Billingsley","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prro.2024.05.007_bib0154","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1148\/radiol.2352040134","article-title":"Head and neck malignancy: is PET\/CT more accurate than PET or CT alone?","volume":"235","author":"Branstetter","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.prro.2024.05.007_bib0155","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/j.ijrobp.2011.05.061","article-title":"Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients","volume":"82","author":"Cao","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.007_bib0156","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1078-0432.CCR-21-2338","article-title":"Early HPV ctDNA kinetics and imaging biomarkers predict therapeutic response in p16+ oropharyngeal squamous cell carcinoma","volume":"28","author":"Cao","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prro.2024.05.007_bib0157","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1158\/1078-0432.CCR-19-2384","article-title":"HPV sequencing facilitates ultrasensitive detection of HPV circulating tumor DNA","volume":"27","author":"Leung","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prro.2024.05.007_bib0158","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-19-0211","article-title":"Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer","volume":"25","author":"Chera","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prro.2024.05.007_bib0159","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12967-020-02330-y","article-title":"Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer","volume":"18","author":"Rutkowski","year":"2020","journal-title":"J Transl Med"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024001395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024001395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T09:16:01Z","timestamp":1725009361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850024001395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":159,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1879850024001395"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2024.05.007","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2024.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}